INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 186 filers reported holding INARI MED INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,197,398 | +27.6% | 94,761 | +13.4% | 0.00% | +100.0% |
| Q2 2023 | $4,857,884 | -14.7% | 83,555 | -9.4% | 0.00% | -50.0% |
| Q1 2023 | $5,695,449 | +75.9% | 92,248 | +81.0% | 0.00% | +100.0% |
| Q4 2022 | $3,238,636 | -29.4% | 50,954 | -19.3% | 0.00% | 0.0% |
| Q3 2022 | $4,589,000 | +2.6% | 63,164 | -4.0% | 0.00% | 0.0% |
| Q2 2022 | $4,474,000 | -83.4% | 65,798 | -77.9% | 0.00% | -85.7% |
| Q1 2022 | $27,012,000 | -1.7% | 298,015 | -1.0% | 0.01% | 0.0% |
| Q4 2021 | $27,478,000 | -81.6% | 301,076 | -83.7% | 0.01% | -78.8% |
| Q3 2021 | $149,459,000 | -5.2% | 1,842,904 | +9.1% | 0.03% | -5.7% |
| Q2 2021 | $157,596,000 | +5.3% | 1,689,492 | +20.8% | 0.04% | +2.9% |
| Q1 2021 | $149,624,000 | +29.8% | 1,398,347 | +5.9% | 0.03% | +21.4% |
| Q4 2020 | $115,268,000 | +232.9% | 1,320,518 | +163.2% | 0.03% | +180.0% |
| Q3 2020 | $34,629,000 | +1564.1% | 501,731 | +1067.7% | 0.01% | +900.0% |
| Q2 2020 | $2,081,000 | – | 42,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |